Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remo Alessandris

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Hepatology|June 22, 2026
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trialsMerve Rousian, Remo Alessandris, Lauren Schleimer, et al.
Annals of Surgery|March 30, 2023
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic SyndromeGiammauro Berardi, Tommy Ivanics, Gonzalo Sapisochin, et al.
Hepatology (Baltimore, Md.)|January 16, 2023
Model to predict major complications following liver resection for HCC in patients with metabolic syndromeGiammauro Berardi, Francesca Ratti, Carlo Sposito, et al.
JHEP Reports : Innovation in Hepatology|July 4, 2024
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndromeGiammauro Berardi, Alessandro Cucchetti, Carlo Sposito, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Hepatology|June 22, 2026
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trialsMerve Rousian, Remo Alessandris, Lauren Schleimer, et al.
Annals of Surgery|March 30, 2023
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic SyndromeGiammauro Berardi, Tommy Ivanics, Gonzalo Sapisochin, et al.
Hepatology (Baltimore, Md.)|January 16, 2023
Model to predict major complications following liver resection for HCC in patients with metabolic syndromeGiammauro Berardi, Francesca Ratti, Carlo Sposito, et al.
JHEP Reports : Innovation in Hepatology|July 4, 2024
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndromeGiammauro Berardi, Alessandro Cucchetti, Carlo Sposito, et al.
Pageof 2